Hepatitis B vaccine at birth

Research on the hepatitis B birth dose looks at safety, effectiveness and delivery of the vaccine in the first hours after birth. Reviews address long-term implications and barriers to use, safety, effectiveness and public health benefit, and the place of the birth dose among routine childhood vaccines given in infancy. Papers from India and low- and middle-income countries ask how the birth dose can be reconsidered or delivered where cold storage is limited.

Many papers focus on how hospitals provide the vaccine. Quality improvement studies describe efforts to improve birth dose rates, including a 24-hour baby bundle, vaccination on delivery wards in Islamabad, and healthcare worker views on system-level barriers in several urban U.S. hospitals. An analysis also considers the economic and health consequences of shared clinical decision-making for the birth dose.

Parents commonly ask why a newborn is offered a vaccine against a liver infection, how it is given and what the research says about safety. The studies continue to examine timing, safety and how conversations with families are handled.

An educator may want slides to explain the purpose of the birth dose accurately and to prepare parents for when it may be offered. The papers below are the ones the Hub tracks on this topic.